The Food and Drug Administration is expected to authorized the use of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds by next week, The New York Times reports.
Why it matters: Opening up vaccine eligibility to young people and children will be crucial as the U.S. works to achieve herd immunity.
